Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:PREFACE
Volume: 17 Issue: 1
Author(s): Emilio Jirillo*
Affiliation:
- Department of Basic Medical Sciences, Neuroscience and Sensory Organs University of Bari, Bari,Italy
Export Options
About this article
Cite this article as:
Jirillo Emilio*, PREFACE, Endocrine, Metabolic & Immune Disorders - Drug Targets 2017; 17 (1) . https://dx.doi.org/10.2174/187153031701170623161132
DOI https://dx.doi.org/10.2174/187153031701170623161132 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gene Profile Identifies Zinc Transporters Differentially Expressed in Normal Human Organs and Human Pancreatic Cancer
Current Molecular Medicine The Metabolic Syndrome and Vascular Disease in Asia
Cardiovascular & Hematological Disorders-Drug Targets VIP Signaling Fails to Alter Gene Expression but Induces Different [cAMP]i Responses in Human Malignant Hut-78 and Molt-4 T Cell Lines; Implications for Different G-protein Coupling for VIP Receptors
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Current Pharmaceutical Design Mutations of mtDNA in some Vascular and Metabolic Diseases
Current Pharmaceutical Design Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall
Current Vascular Pharmacology Preface (Hot Topic:Cardiovascular and Hematological Disorders Executive Editor: Dr. Johann Auer)
Current Pharmaceutical Design Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury
Recent Patents on CNS Drug Discovery (Discontinued) A Hopeful Prospect of Riociguat as a Soluble Guanylate Cyclase Stimulator for Management of Pressure Ulcers
Current Drug Discovery Technologies Treating Diabetes Mellitus in Older and Oldest Old Patients
Current Pharmaceutical Design Actin and Keratin are Binding Partners of the 1,25D<sub>3</sub>-MARRS Receptor/PDIA3/ERp57
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Effects of Nannochloropsis Fed on Serum and Tissue Lipids Metabolism in Obese Offspring of Overfed Dams
Current Nutrition & Food Science Patent Selections
Recent Patents on Nanotechnology Oral Chemotherapy in Elderly Women with Metastatic Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry A Broad Variety of Antigens Contribute to the Pathogenesis of Atherosclerosis: How to Neutralize Noxious Reactions in the Host
Endocrine, Metabolic & Immune Disorders - Drug Targets Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?
Anti-Cancer Agents in Medicinal Chemistry Advanced Methods for the Analysis of Testosterone
Current Medicinal Chemistry Role of Advanced Glycation End Products (AGEs) in Thrombogenic Abnormalities in Diabetes
Current Neurovascular Research Advances in Drug Safety
Current Pharmaceutical Design The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome
Current Drug Metabolism